Eagle

Main information

Documents

Localization

  • Available in:
  • Eagle MAG Restore Tablets
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 219317
  • Last update:
  • 08-10-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

219317

Eagle MAG Restore Tablets

ARTG entry for

Medicine Listed

Sponsor

Integria Healthcare Australia Pty Ltd

Postal Address

PO Box 4854,EIGHT MILE PLAINS, QLD, 4113

Australia

ARTG Start Date

16/01/2014

Product category

Medicine

Status

Active

Approval area

Listed Medicines

Conditions

Colouring agents used in listed medicine for ingestion, other than those listed for export only under section 25 of the Act, shall be only those included in

the list of 'Colourings permitted in medicines for oral use'.

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine,

(b) Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is

sub-contracted to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be

kept.

The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records

to the Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

The sponsor of the listed medicine must not, by any means, intentionally or recklessly advertise the medicine for an indication other than those accepted

in relation to the inclusion of the medicine in the Register.

All reports of adverse reactions or similar experiences associated with the use or administration of the listed medicine shall be notified to the Head, Office

of Product Review, Therapeutic Goods Administration, as soon as practicable after the sponsor of the goods becomes aware of those reports. Sponsors

of listed medicines must retain records of such reports for a period of not less than 18 months from the day the Head, Office of Product Review is notified

of the report or reports.

The sponsor shall not supply the listed medicine after the expiry date of the goods.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine

outside Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National

Manager Therapeutic Goods Administration, immediately the action or information is known to the sponsor.

Products

1. Eagle MAG Restore Tablets

Product Type

Single Medicine Product

Effective date

31/08/2017

Warnings

Vitamins can only be of assistance if the dietary vitamin intake is inadequate. OR Vitamin supplements should not replace a balanced diet.

If symptoms persist consult your healthcare practitioner (or words to that effect).

For practitioner dispensing only.

WARNING - this medication may be dangerous when used in large amounts or for a long time; or WARNING - this product contains [insert pyridoxine

hydrochloride or pyridoxal 5-phosphate as applicable], which may be dangerous when used in large amounts or for a long time.

WARNING - Stop taking this medication if you experience tingling, burning or numbness and see your healthcare practitioner as soon as possible.

[Contains vitamin B6].

Standard Indications

Aids or assists in the prevention of muscular cramps and spasms.

Prevention/treatment of vitamin [XX] and/or mineral [YY] and/or nutritional deficiencies (This indication is not be to used for the treatment of iron

deficiency conditions).

May assist in the maintenance of normal healthy blood sugar/glucose levels in healthy individuals.

Beneficial during times of stress. [Warning S required]

For vitamin (may state the vitamin) supplementation.

Relief of muscular cramps and spasms. [Warning S required]

For mineral (may state the mineral) supplementation.

May assist in the management of pre-menstrual tension/syndrome. [Warning S required]

For the symptomatic relief of pre-menstrual tension/syndrome. [Warning S required]

May assist in the maintenance of normal healthy blood sugar/glucose balance in healthy individuals.

Relief of pre-menstrual symptoms/syndrome. [Warning S required]

Specific Indications

Provides relief from muscular cramps and spasms caused my magnesium deficiency

Magnesium plays an important role in skeletal and smooth muscle relaxation

Public Summary

Page 1 of

Produced at 26.11.2017 at 03:48:19 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

Helps to support cardiovascular function

Magnesium plays a role in the maintenance of healthy blood sugar levels in healthy individuals

People who suffer with recurrent migraines appear to have lower intracellular magnesium levels

Magnesium amino acid chelate & magensium aspartate are better absorbed than Magnesium oxide in healthy individuals

Additional Product information

Pack Size/Poison information

Pack Size

Poison Schedule

Components

1. Formulation 1

Dosage Form

Tablet, film coated

Route of Administration

Oral

Visual Identification

Active Ingredients

calcium hydrogen phosphate dihydrate

312.47 mg

dibasic potassium phosphate

51.43 mg

Magnesium amino acid chelate

368.5 mg

magnesium aspartate tetrahydrate

237.3 mg

magnesium phosphate pentahydrate

369 mg

Manganese amino acid chelate

25 mg

pyridoxine hydrochloride

25.45 mg

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 2 of

Produced at 26.11.2017 at 03:48:19 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information